Back to top
more

CoDiagnostics (CODX)

(Delayed Data from NSDQ)

$1.29 USD

1.29
91,670

-0.07 (-4.81%)

Updated Jul 15, 2024 03:58 PM ET

After-Market: $1.29 +0.01 (0.39%) 7:38 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.15%
2Buy17.88%
3Hold9.47%
4Sell5.14%
5Strong Sell2.57%
S&P50011.11%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

F Value F Growth F Momentum F VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 36% (89 out of 250)

Industry: Medical Services

Better trading starts here.

Zacks News

Why Seasoned Investors are Retaining Select Medical (SEM) Stock

Select Medical (SEM) is focused on making strategic acquisitions to boost its business through inorganic growth.

Acadia (ACHC) & Orlando Health Form JV, Boosts Presence

Acadia Healthcare Company (ACHC) expects to take on Orlando Health South Seminole Hospital's management responsibilities of the behavioral health program.

Why Seasoned Investors are Retaining Acadia (ACHC) Stock

Acadia Healthcare's (ACHC) buyouts are helping the company to add facilities, beds and hospitals to its network and contributing to its top line.

Teladoc (TDOC) Falls 8.1% Despite Upbeat Revenue Guidance

Teladoc Health (TDOC) expects revenues to rise to more than $4 billion in 2024.

Analysts Estimate CoDiagnostics, Inc. (CODX) to Report a Decline in Earnings: What to Look Out for

CoDiagnostics, Inc. (CODX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

CoDiagnostics, Inc. (CODX) Just Reclaimed the 20-Day Moving Average

Good things could be on the horizon when a stock surpasses the 20-day simple moving average. How should investors react?

CoDiagnostics, Inc. (CODX) Surpasses Q2 Earnings and Revenue Estimates

CoDiagnostics, Inc. (CODX) delivered earnings and revenue surprises of 43.48% and 30.28%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?

Analysts Estimate CoDiagnostics, Inc. (CODX) to Report a Decline in Earnings: What to Look Out for

CoDiagnostics, Inc. (CODX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Strength Seen in CoDiagnostics, Inc. (CODX): Can Its 9.7% Jump Turn into More Strength?

CoDiagnostics, Inc. (CODX) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.

Are Investors Undervaluing CoDiagnostics, Inc. (CODX) Right Now?

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

Zacks Value Investor Highlights: Hibbett Sports, CoDiagnostics, Quidel Corp, DHT Holdings and Rocket Companies

Zacks Value Investor Highlights: Hibbett Sports, CoDiagnostics, Quidel Corp, DHT Holdings and Rocket Companies

Tracey Ryniec headshot

Screening for Ben Graham Value Stocks

What kind of value stocks would Ben Graham, the father of value investing, be looking at in 2021?

CoDiagnostics, Inc. (CODX) Beats Q1 Earnings and Revenue Estimates

CoDiagnostics, Inc. (CODX) delivered earnings and revenue surprises of 30.00% and 2.69%, respectively, for the quarter ended March 2021. Do the numbers hold clues to what lies ahead for the stock?

CoDiagnostics, Inc. (CODX) Earnings Expected to Grow: Should You Buy?

CoDiagnostics, Inc. (CODX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

CoDiagnostics, Inc. (CODX) Q4 Earnings Lag Estimates

CoDiagnostics, Inc. (CODX) delivered earnings and revenue surprises of -12.24% and 1.55%, respectively, for the quarter ended December 2020. Do the numbers hold clues to what lies ahead for the stock?

Co-Diagnostics (CODX) to Post Q3 Earnings: What's in Store?

Co-Diagnostics' (CODX) third-quarter results are likely to reflect higher COVID-19 test sales.

CoDiagnostics, Inc. (CODX) Gains But Lags Market: What You Should Know

CoDiagnostics, Inc. (CODX) closed the most recent trading day at $14.42, moving +0.07% from the previous trading session.

Implied Volatility Surging for Co-Diagnostics (CODX) Stock Options

Investors need to pay close attention to Co-Diagnostics (CODX) stock based on the movements in the options market lately.

Company News for Oct 5, 2020

Companies in the news are: UBER, WMT, BBBY, CODX

CoDiagnostics, Inc. (CODX) Q2 Earnings and Revenues Miss Estimates

CoDiagnostics, Inc. (CODX) delivered earnings and revenue surprises of -29.51% and -10.96%, respectively, for the quarter ended June 2020. Do the numbers hold clues to what lies ahead for the stock?

Co-Diagnostics (CODX) to Post Q2 Earnings: What's in Store?

Co-Diagnostics' (CODX) second-quarter results are likely to reflect higher COVID-19 test sales.

CoDiagnostics, Inc. (CODX) Stock Sinks As Market Gains: What You Should Know

In the latest trading session, CoDiagnostics, Inc. (CODX) closed at $25.73, marking a -1.61% move from the previous day.

CoDiagnostics, Inc. (CODX) Earnings Expected to Grow: What to Know Ahead of Q2 Release

CoDiagnostics, Inc. (CODX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

CoDiagnostics, Inc. (CODX) Outpaces Stock Market Gains: What You Should Know

In the latest trading session, CoDiagnostics, Inc. (CODX) closed at $22.12, marking a +1.37% move from the previous day.

Advanced Micro Devices, Under Armour, Immunomedics, GenMark and Co-Diagnostics highlighted as Zacks Bull and Bear of the Day

Advanced Micro Devices, Under Armour, Immunomedics, GenMark and Co-Diagnostics highlighted as Zacks Bull and Bear of the Day